MRPL13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.272400E-01
Normal-vs-Stage2
2.605800E-01
Normal-vs-Stage3
7.928000E-01
Normal-vs-Stage4
4.537200E-01
Stage1-vs-Stage2
5.705800E-01
Stage1-vs-Stage3
7.201200E-01
Stage1-vs-Stage4
8.966000E-01
Stage2-vs-Stage3
3.505600E-01
Stage2-vs-Stage4
7.632000E-01
Stage3-vs-Stage4
6.547400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.894200E-01
Normal-vs-AfricanAmerican
5.671800E-01
Normal-vs-Asian
1.832610E-01
Caucasian-vs-AfricanAmerican
3.190400E-01
Caucasian-vs-Asian
6.372000E-01
AfricanAmerican-vs-Asian
1.720030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.048800E-01
Normal-vs-Female
2.574800E-01
Male-vs-Female
8.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.083000E-01
Normal-vs-Age(41-60Yrs)
1.377200E-01
Normal-vs-Age(61-80Yrs)
3.855600E-01
Normal-vs-Age(81-100Yrs)
7.007800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.363600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.342000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.482500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.601020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.585800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.641200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.346400E-01
Normal-vs-Daily Drinker
2.889400E-01
Normal-vs-Weekly Drinker
5.542600E-01
Normal-vs-Occasional Drinker
1.111010E-01
Normal-vs-Social Drinker
3.187400E-01
Non Drinker-vs-Daily Drinker
5.322600E-01
Non Drinker-vs-Weekly Drinker
8.838000E-01
Non Drinker-vs-Occasional Drinker
2.441800E-02
Non Drinker-vs-Social Drinker
6.082000E-01
Daily Drinker-vs-Weekly Drinker
7.659000E-01
Daily Drinker-vs-Occasional Drinker
1.044960E-01
Daily Drinker-vs-Social Drinker
2.505200E-01
Weekly Drinker-vs-Occasional Drinker
1.453000E-01
Weekly Drinker-vs-Social Drinker
6.754200E-01
Occasional Drinker-vs-Social Drinker
1.146050E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.722600E-01
Normal-vs-Grade 2
9.204400E-01
Normal-vs-Grade 3
9.867400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.538800E-01
Grade 1-vs-Grade 3
4.150500E-02
Grade 1-vs-Grade 4
8.722600E-01
Grade 2-vs-Grade 3
5.428000E-02
Grade 2-vs-Grade 4
9.204400E-01
Grade 3-vs-Grade 4
9.867400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.883200E-01
Normal-vs-NonDiabetic
2.624200E-01
Diabetic-vs-NonDiabetic
8.854400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.316200E-02
Normal-vs-NoPancreatitis
3.157400E-01
Pancreatitis-vs-NoPancreatitis
5.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.286200E-01
Normal-vs-N1
2.850800E-01
N0-vs-N1
4.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.739600E-02
Normal-vs-TP53-NonMutant
5.660800E-01
TP53-Mutant-vs-TP53-NonMutant
1.69410000028236E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
